Model Number 1973-03 |
Device Problems
Difficult to Remove (1528); Difficult to Advance (2920); Failure to Deflate (4060)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/22/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
A1 - patient identifier: (b)(6).A2 - age at time of event: the subject was 70 years old at the time of study enrollment.
|
|
Event Description
|
S2444 elegance.It was reported that the balloon was unable to be fully deflated.The subject underwent treatment with the ranger drug coated balloons on (b)(6) 2022 as a part of the elegance clinical trial.The target lesion #001 was in the left common femoral artery with proximal reference vessel diameter of 7 mm and distal reference vessel diameter of 6.5 mm with lesion length of 60 mm and 70% stenosis and was classified as tasc ii a lesion.Prior to target lesion treatment, lithotripsy was performed using a non-boston scientific device and treatment of target lesion was performed by study device of 7.0 mm x 80 mm ranger drug coated balloon.Post treatment the final residual stenosis was noted to be 10%.The target lesion #002 was in the right common femoral artery, right ostial superficial femoral artery (sfa) extending into right proximal sfa with proximal reference vessel diameter of 6.5 mm and distal reference vessel diameter of 6.0 mm with lesion length of 80 mm and 100% stenosis and was classified as tasc ii d lesion.Prior to target lesion treatment, a non-boston scientific embolization protection device was placed, followed by atherectomy and lithotripsy using two non-boston scientific devices.Treatment of target lesion was performed by study device, 6 mm x 60 mm ranger drug coated balloon.Post treatment, the final residual stenosis was noted to be 10%.During the index procedure, the 7 mm x 40 mm ranger drug coated balloon was unable to cross the right mid cfa and hence, device was removed and was not used.On the same day, subsequently, attempts to deliver 6 mm x 60 mm ranger drug coated balloon were unsuccessful.Hence a 0.018-inch non-boston scientific guidewire was advanced into the right sfa, over which delivery of the 6 mm x 60 mm ranger drug coated balloon was successful and was used to treat the right ostial sfa and cfa.Post treatment, the 6 mm x 60 mm ranger drug coated balloon was not fully deflated during the withdrawal and was stuck inside the radial sheath.Hence, the balloon and sheath were removed as one unit.On (b)(6) 2022, subject was discharged with aspirin.
|
|
Event Description
|
S2444 elegance.It was reported that the balloon was unable to be fully deflated.The subject underwent treatment with the ranger drug coated balloons on (b)(6) 2022 as a part of the elegance clinical trial.The target lesion #001 was in the left common femoral artery with proximal reference vessel diameter of 7 mm and distal reference vessel diameter of 6.5 mm with lesion length of 60 mm and 70% stenosis and was classified as tasc ii a lesion.Prior to target lesion treatment, lithotripsy was performed using a non-boston scientific device and treatment of target lesion was performed by study device of 7.0 mm x 80 mm ranger drug coated balloon.Post treatment the final residual stenosis was noted to be 10%.The target lesion #002 was in the right common femoral artery, right ostial superficial femoral artery (sfa) extending into right proximal sfa with proximal reference vessel diameter of 6.5 mm and distal reference vessel diameter of 6.0 mm with lesion length of 80 mm and 100% stenosis and was classified as tasc ii d lesion.Prior to target lesion treatment, a non-boston scientific embolization protection device was placed, followed by atherectomy and lithotripsy using two non-boston scientific devices.Treatment of target lesion was performed by study device, 6 mm x 60 mm ranger drug coated balloon.Post treatment, the final residual stenosis was noted to be 10%.During the index procedure, the 7 mm x 40 mm ranger drug coated balloon was unable to cross the right mid cfa and hence, device was removed and was not used.On the same day, subsequently, attempts to deliver 6 mm x 60 mm ranger drug coated balloon were unsuccessful.Hence a 0.018-inch non-boston scientific guidewire was advanced into the right sfa, over which delivery of the 6 mm x 60 mm ranger drug coated balloon was successful and was used to treat the right ostial sfa and cfa.Post treatment, the 6 mm x 60 mm ranger drug coated balloon was not fully deflated during the withdrawal and was stuck inside the radial sheath.Hence, the balloon and sheath were removed as one unit.On (b)(6) 2022, subject was discharged with aspirin.It was further reported that the target lesion #002 was in the right common femoral artery, and right ostial sfa.The target lesion did not extend into the right proximal sfa, as was previously reported.Additionally, post index procedure angiography revealed that there was no injury caused by partially deflated balloon and less than 20% residual stenosis was noted in the right common femoral artery, profunda femoris artery, and sfa, with no evidence of contrast extravasation.Furthermore, the medication the patient was discharged with on (b)(6) 2022 was updated from aspirin to dual antiplatelet therapy.
|
|
Manufacturer Narrative
|
Corrected fields: b5.A1 - patient identifier: (b)(6).A2 - age at time of event: the subject was 70 years old at the time of study enrollment.
|
|
Search Alerts/Recalls
|
|